P685: Effectiveness of a second-line anti-TNFɑ agent compared to a different mechanism of action after first anti-TNFɑ failure in ulcerative colitis: CambiaCU StudyECCO'24Year: 2024
Authors: López-Vico, M.(1)*;Hernández-Martínez, Á.(2);Soto-Escribano, P.(3);Rojas-Feria, M.(4);Cornejo-Jiménez, A.(4);Caballero-Mateos, A.M.(5);Trapero-Martínez, A.M.(6);Sánchez-Capilla, A.D.(7);Cabello-Tapia, M.J.(7);Martín-Rodríguez, M.D.M.(7);
(1)Virgen de las Nieves University Hospital, Gastroenterology and Hepatology, Granada, Spain;(2)Hospital Universitario Torrecárdenas, Gastroenterology Unit, Almería, Spain;(3)Hospital Universitario Reina Sofía, Gastroenterology Unit, Córdoba, Spain;(4)Hospital Universitario Virgen del Rocío, Gastroenterology Unit, Sevilla, Spain;(5)Hospital Santa Ana de Motril, Gastroenterology Unit, Motril, Spain;(6)Hospital Universitario de Jaén, Gastroenterology Unit, Jaén, Spain;(7)Hospital Universitario Virgen de la Nieves, Gastroenterology Unit, Granada, Spain;
P687: Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)ECCO'24Year: 2024
Authors: Matsuoka, K.(1)*;Nakase, H.(2);Fujii, T.(3);Hisamatsu, T.(4);Suzuki, Y.(5);Watanabe, M.(6);Uchikawa, Y.(7);Goto, S.(7);Fujimoto, G.(8);Zhang, C.(7);Hibi, T.(9);
(1)Toho University Sakura Medical Center, Division of Gastroenterology and Hepatology- Department of Internal Medicine, Chiba, Japan;(2)Sapporo Medical University School of Medicine, Department of Gastroenterology and Hepatology, Hokkaido, Japan;(3)Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan;(4)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Tokyo, Japan;(5)Ginza Central Clinic, Gastroenterology, Tokyo, Japan;(6)Tokyo Medical and Dental University, Advanced Research Institute, Tokyo, Japan;(7)Bristol Myers Squibb K.K., Immunology- Cardiovascular & Neuroscience TA Clinical Development, Tokyo, Japan;(8)Bristol Myers Squibb K.K., Biometrics & Data Sciences, Tokyo, Japan;(9)Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan;
P688: Comparative Effectiveness of Ustekinumab Versus Vedolizumab in Treating Crohn’s Disease After Failure of Anti-TNF Agents: Real-World EvidenceECCO'24Year: 2024
Authors: Alamer, A.(1);Al Lehaibi, L.(2);Alomar, M.(2);Aldhuwayan, F.(2);Alshouish, S.(2);Al-Ali, A.(3);Almudhry, Z.(4);Almulhim, A.(5);Althagafi, A.(6);Aldosari, S.(7);Alameel, T.(8)*;
(1)Prince Sattam Bin Abdulaziz University, Department of Clinical Pharmacy, Alkharj, Saudi Arabia;(2)Eastern Health Cluster- Dammam Medical Complex, Department of Clinical Pharmacy, Dammam, Saudi Arabia;(3)Eastern Health Cluster- Dhahran Eye Specialist Hospital, Department of Clinical Pharmacy, Dhahran, Saudi Arabia;(4)Eastern Health Cluster- Dammam Medical Complex, Department of Medicine, Dammam, Saudi Arabia;(5)King Faisal University, Department of Pharmacy Practice- College of Clinical Pharmacy, Alhofuf, Saudi Arabia;(6)King Abdulaziz University, Department of Pharmacy Practice- Faculty of Pharmacy, Jeddah, Saudi Arabia;(7)Prince Sattam Bin Abdulaziz University, Department of Clinical Pharmacy- College of Pharmacy, Alkharj, Saudi Arabia;(8)King Fahad Specialist Hospital Dammam, Department of Medicine, Dammam, Saudi Arabia;
P689: Adaptive steroid tapering impedes corticosteroid-free remissions compared to forced tapering in UC clinical trialsECCO'24Year: 2024
Authors: Narula, N.(1)*;Hamam, H.(1);Wong, E.C.(1);Marshall, J.K.(1);Jairath, V.(2);Hanauer, S.B.(3);Reinisch, W.(4);Dulai, P.S.(3);
(1)McMaster University, Gastroenterology, Hamilton, Canada;(2)Western University, Gastroenterology, London, Canada;(3)Northwestern University, Gastroenterology, Chicago, United States;(4)Medical University of Vienna, Gastroenterology, Vienna, Austria;
P690: Monitoring ustekinumab levels in Inflammatory Bowel Disease in clinical practice: a window of opportunity.ECCO'24Year: 2024
Authors: González Antuña, J.(1)*;Valdés Delgado, T.(1);Maldonado Pérez, B.(1);Castro Laria, L.(1);Merino Bohórquez, V.(2);Calleja Hernández, M.Á.(2);Argüelles Arias, F.(1);
(1)Virgen Macarena University Hospital, Gastroenterology Department, Seville, Spain;(2)Virgen Macarena University Hospital, Pharmacy Department, Seville, Spain;
P691: Intestinal ultrasonography accuracy in the evaluation of patients with moderate to severe ulcerative colitis starting infliximab therapyECCO'24Year: 2024
Authors: Albshesh, A.(1)*;Melnik , P.(2);Dotan , A.(2);Lahat , A.(2);Ungar, B.(2);Ben-Horin, S.(2);Carter, D.(2);Kopylov , U.(2);
(1)Sheba Medical Center, Department of Gastroenterology, Ramat Gan, Israel;(2)Sheba Medical Center and Sackler School of Medicine- Tel-Aviv University, Department of Gastroenterology, Ramat Gan, Israel;
P692: An IBD nurse-led educational programme on safety and efficacy of adjuvated recombinant zoster vaccine can improve vaccine uptake in IBD patients on immunosuppressive treatment.ECCO'24Year: 2024
Authors: Zaetta, D.(1)*;Roncen, E.(1);Franco, M.(1);Riguccio, G.(1);Santarossa, A.(2);Buda, A.(3);De Bona, M.(1);
(1)AULSS1 Dolomiti- Gastrointestinal Inflammatory Disease Departmental Unit- S. Maria del Prato Hospital, Gastrointestinal Oncological Surgery, Feltre, Italy;(2)AULSS1 Dolomiti- Nursing Human Resources- S. Maria del Prato Hospital, Medical Direction, Feltre, Italy;(3)AULSS1 Dolomiti- Gastroenterology- S. Maria del Prato Hospital, Gastrointestinal Oncological Surgery, Feltre, Italy;
P693: Care needs and reasons for (not) seeking care among fatigued patients with Inflammatory Bowel Disease: A qualitative studyECCO'24Year: 2024
Authors: Bredero, Q.(1)*;ter Avest, M.M.(2,3,4);Fleer, J.(1);Dijkstra, G.(5);Schroevers, M.J.(1);
(1)University Medical Center Groningen, Department of Health psychology, Groningen, The Netherlands;(2)Radboud University Medical Center, Center for Mindfulness- Department of Psychiatry, Nijmegen, The Netherlands;(3)Jeroen Bosch Hospital, Department of Gastroenterology and Hepatology, ‘s-Hertogenbosch, The Netherlands;(4)Radboud University, Donders Institute for Brain- Cognition and Behavior, Nijmegen, The Netherlands;(5)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;
P694: Age is a strong of predictive risk factor for anti-TNF therapy related adverse events in IBD patients.ECCO'24Year: 2024
Authors: Majumder, S.(1,2,3,4)*;Bhaduri, A.(5);Sharma, N.(4);Mohammed Nabil Quraishi, N.Q.(4);Cooney, R.(4);Ghosh, S.(1);Iacucci, M.(1,3,4,6);Shivaji, U.N.(3,4,6,7);
(1)APC Microbiome Ireland- College of Medicine and Health- University College Cork- Ireland, Medicine, Cork, Ireland;(2)NH Narayana Health- Bangalore- India, Clinical Research, Bangalore, India;(3)Institute of Immunology and Immunotherapy- University of Birmingham- UK, Immunology and Immunotherapy, Birmingham, United Kingdom;(4)University Hospitals Birmingham NHS Foundation Trust- Birmingham- UK, Gastroenterology, Birmingham, United Kingdom;(5)Dhiyo Healthcare Analytics- Bangalore, Bioinformatics, Bangalore, India;(6)National Institute for Health Research NIHR Birmingham Biomedical Research Centre- University of Birmingham and University Hospitals Birmingham NHS Foundation Trust- UK, Health Research, Birmingham, United Kingdom;(7)Mazumdar-Shaw Medical Centre- A Unit of NH Narayana Health- Bangalore- India, Gastroenterology, Bangalore, India;
P695: Untargeted proteomics analysis of baseline serum samples prior to biologic therapy initiationECCO'24Year: 2024
Authors: Rauch, M.(1)*;Laponogov, I.(2);van Welsen, I.(3);Quinn, A.(4);Joustra, V.(3);Paulich, H.(3);Camesella Perez, B.(4);Ramkisoen, R.(3);Noble, A.(4);Satsangi, J.(4);D’Haens, G.(3);Williamson, A.(1);Veselkov, K.(2);van @E@t Wout, A.(1);
(1)AlphaBiomics, Research and Development, London, United Kingdom;(2)Intelligify, Research and Development, London, United Kingdom;(3)Amsterdam University Medical Centers, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(4)University of Oxford, Nuffield Department of Experimental Medicine, Oxford, United Kingdom;
P696: Initiation of Vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A Prospective Study Including Rheumatological and Blinded Imaging Assessments.ECCO'24Year: 2024
Authors: Rohekar, S.(1);Boyd, T.(1);Lambert, R.(2);Beaton, M.(3);Chande, N.(4);Gregor, J.(3);Lennox, H.(5);McIntosh, K.(3);Ponich, T.(3);Rahman, A.(3);Sharma, T.(6);Sey, M.(3);Tauqir, M.(7);Jairath, V.(3)*;
(1)Schulich School of Medicine & Dentistry- Western University, Department of Medicine- Division of Rheumatology, London, Canada;(2)University of Alberta, Department of Radiology & Diagnostic Imaging, Edmonton, Canada;(3)Western University, Department of Medicine- Division of Gastroenterology, London, Canada;(4)Southwestern Ontario Inflammatory Bowel Disease Clinic, Southwestern Ontario Inflammatory Bowel Disease Clinic, London, Canada;(5)London Health Sciences Centre, Gastroenterology, London, Canada;(6)Lawson Health Research Institute, Rheumatology, London, Canada;(7)Schulich School of Medicine & Dentistry- Western University, Schulich School of Medicine & Dentistry, London, Canada;
P697: Short- and long-term outcomes following biologic use before non-conventional stricureplasty for Crohn’s JejunoileitisECCO'24Year: 2024
Authors: Belkovsky, M.(1)*;Cohen, B.(2);Sommovilla, J.(1);Hull, T.(1);Holubar , S.(1);
(1)Cleveland Clinic, Colorectal Surgery, Cleveland, United States;(2)Cleveland Clinic, Gastroenterology- Hepatology & Nutrition, Cleveland, United States;
P698: Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentre Real-World Observational Study.ECCO'24Year: 2024
Authors: ParraPhD, R.(1)*;Chebli, J.M.F.(2);Freitas Cardoso de Azevedo, M.(3);Chebli, L.A.(2);Zabot, G.P.(4);Cassol, O.S.(5);Fróes, R.D.S.B.(6);Santana, G.O.(7);Lubini, M.(8);Magro, D.O.(9);Imbrizi, M.(9);Moraes, A.C.S.(10);Teixeira, F.V.(11);Alves Jr, A.J.T.(12);Gasparetti Junior, N.L.T.(13);Ferreira, S.D.C.(14);Queiroz, N.S.F.(15);Kotze, P.G.(16);Féres, O.(17);
(1)University of Sao Paulo, Department of Surgery and Anatomy, Ribeirao Preto, Brazil;(2)Federal University of Juiz de Fora UFJF, Department of Medicine- Inflammatory Bowel Disease Center, Juiz de Fora, Brazil;(3)University of São Paulo School of Medicine, Gastroenterology, São Paulo, Brazil;(4)Moinhos de Vento Hospital- Feevale University, Colorectal Surgery, Porto Alegre, Brazil;(5)Hospital de Clínicas de Passo Fundo- Atitus Medical School, Colorectal Surgery, Passo Fundo, Brazil;(6)Gastromed, Department of Gastroenterology and Endoscopy, Rio de Janeiro, Brazil;(7)State University of Bahia, Gastroenterology, Salvador, Brazil;(8)Passo Fundo University, Gastroenterology, Passo Fundo, Brazil;(9)State University of Campinas UNICAMP, Surgery, Campinas, Brazil;(10)Hospital Copa D´Or. Rio de Janeiro, Internal Medicine, Rio de Janeiro, Brazil;(11)Gastrosaude Clinic, Gastroenterology, Marília, Brazil;(12)Pontifícia Universidade Católica de Campinas, Surgery, Campinas, Brazil;(13)Hospital Vivalle Rede Dor, Surgery, São José dos Campos, Brazil;(14)Ribeirao Preto Medical School- University of São Paulo, Gastroenterology, Ribeirao Preto, Brazil;(15)Health Sciences Graduate Program- Pontifícia Universidade Católica do Paraná PUCPR, IBD Center- Santa Cruz Hospital, Curitiba, Brazil;(16)Health Sciences Postgraduate Program- Pontificia Universidade Católica do Paraná PUCPR, Surgery, Curitiba, Brazil;(17)Ribeirao Preto Medical School- University of São Paulo, Surgery and Anatomy, Ribeirão Preto, Brazil;
P701: Evaluation of the effectiveness of vedolizumab in patients with Crohn@E@s disease: a multicenter real-life study from Argentina.ECCO'24Year: 2024
Authors: Balderramo, D.C.(1)*;Etchevers, J.(2);Fuxman, C.(3);Lubrano, P.(4);Bellicoso, M.(5);Correa, G.(6);Trakal, J.(7);Defago, M.R.(8);Montero, J.(9);Toro, M.(10);Novillo, A.(11);Bonardo, M.(12);Arancibia, N.(13);Motañez, S.(14);Quines, S.(15);Huernos, S.(16);Gil, A.(17);Gonzalez, R.(18);Goncalves, S.(19);
(1)IBD section, Gastroenterology Department. Hospital Privado Universitario de Cordoba. Instituto Universitario de Ciencias Biomedicas de Cordoba, Cordoba, Argentina;(2)Hospital Italiano de Buenos Aires, Gastroenterology Department, Buenos Aires, Argentina;(3)Fundación Favaloro, Gastroenterology Department, Buenos Aires, Argentina;(4)Sanatorio Mater-Dei, Gastroenterology Department, Buenos Aires, Argentina;(5)Inmunología Buenos Aires, Gastroenterology Section, Buenos aires, Argentina;(6)Hospital San Martín de la Plata, IBD section, La Plata, Argentina;(7)Clínica Reina Fabiola, Gastroenterology Department, Cordoba, Argentina;(8)Instituto Humana, Gastroenterology Section, Cordoba, Argentina;(9)Hospital Provincial del Centenario, Gastroenterology Department, Rosario, Argentina;(10)HIGEA Centro Médico, Gastroenterology Department, Mendoza, Argentina;(11)Sanatorio 9 de Julio, Gastroenterology Department, Tucuman, Argentina;(12)Bienestar GECIP, Gastroenterology Department, Cipolletti, Argentina;(13)Sanatorio Argentino, Gastroenterology Department, San Juan, Argentina;(14)Hospital Marcial Quiroga, Gastroenterology Department, San Juan, Argentina;(15)Centro de Estudios Digestivos, Gastroenterology Department, Mar del Plata, Argentina;(16)CEIDI. Consultorio de Enfermedades Inflamatorias del Intestino, IBD section, Buenos Aires, Argentina;(17)CEIDI. Consultorio de Enfermedades Inflamatorias del Intestino., IBD section, Buenos Aires, Argentina;(18)Hospital Aleman, Gastroenterology Department, Buenos Aires, Argentina;(19)CEIDI. Consultorio de Enfermedades Inflamatorias del Intestino. GEDYT, IBD section, Buenos Aires, Argentina;
P702: Long term outcomes following de-escalation of dose-intensified ustekinumab in patients with Crohn’s diseaseECCO'24Year: 2024
Authors: Demase, K.(1)*;Smith, R.L.(1);Luber, R.(1);Taylor, K.M.(1);Ward, M.G.(1);Sparrow, M.P.(1);Little, R.D.(1);
(1)Alfred Health and Monash University, Gastroenterology, Melbourne, Australia;
P703: Comparison of infliximab and adalimumab therapies Persistence in patients with Ulcerative Colitis: Results from a Single Tertiary Turkish IBD Center CohortECCO'24Year: 2024
Authors: Eroglu, Z.(1);Yilmaz, V.(2)*;Guvenir, T.(2);Er, R.E.(2);Toruner, M.(3);
(1)Ankara University School of Medicine, Department of Internal Medicine, Ankara, Turkey;(2)Ankara University School of Medicine, Department of Gastroenterology, Ankara, Turkey;(3)Ankara University Medical School- Ibni-sina Hospital, Department of Gastroenterology, Ankara, Turkey;
P704: Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients with a HIstoRy of CancEr: The SAPPHIRE RegistryECCO'24Year: 2024
Authors: AxelradMD- MPH, J.(1)*;Jiang, Y.(2);Colombel, J.F.(3);Scherl, E.(4);Lukin, D.(4);Chang, S.(1);Chen, L.(5);Katz, S.(1);Kwah, J.(1);Swaminath , A.(6);Sultan, K.(6);Villagra, C.(3);Jandorf, L.(3);Itzkowitz, S.(3);
(1)NYU Grossman School of Medicine, Medicine, New York, United States;(2)Duke University, Practice of Statistical Science, Durham, United States;(3)Icahn School of Medicine at Mount Sinai, Medicine, New York, United States;(4)Weill Cornell Medicine, Medicine, New York, United States;(5)Robert Wood Johnson Medical School, Medicine, New Brunswick, United States;(6)Zucker School of Medicine, Medicine, New York, United States;
